[HTML][HTML] COVID-19 vaccines: where we stand and challenges ahead

G Forni, A Mantovani - Cell Death & Differentiation, 2021 - nature.com
In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its
genome, an exceptional effort by the scientific community has led to the development of over …

[HTML][HTML] Transition to endemicity: Understanding COVID-19

R Antia, ME Halloran - Immunity, 2021 - cell.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its
associated disease, coronavirus disease 2019 (COVID-19), has caused a devastating …

[HTML][HTML] COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

M Schwarzinger, V Watson, P Arwidson… - The Lancet Public …, 2021 - thelancet.com
Background Opinion polls on vaccination intentions suggest that COVID-19 vaccine
hesitancy is increasing worldwide; however, the usefulness of opinion polls to prepare mass …

[HTML][HTML] Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

S Dispinseri, M Secchi, MF Pirillo, M Tolazzi… - Nature …, 2021 - nature.com
Understanding how antibody responses to SARS-CoV-2 evolve during infection may
provide important insight into therapeutic approaches and vaccination for COVID-19. Here …

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

JM Dan, J Mateus, Y Kato, KM Hastie, ED Yu, CE Faliti… - Science, 2021 - science.org
INTRODUCTION Immunological memory is the basis for durable protective immunity after
infections or vaccinations. Duration of immunological memory after severe acute respiratory …

Immunological characteristics govern the transition of COVID-19 to endemicity

JS Lavine, ON Bjornstad, R Antia - Science, 2021 - science.org
We are currently faced with the question of how the severity of infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) may change in the years ahead. Our …

Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes

CM Saad-Roy, SE Morris, CJE Metcalf, MJ Mina… - Science, 2021 - science.org
INTRODUCTION As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic continues, the deployment of safe and effective vaccines presents a key …

[HTML][HTML] Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection

S Adamo, J Michler, Y Zurbuchen, C Cervia… - Nature, 2022 - nature.com
Immunological memory is a hallmark of adaptive immunity and facilitates an accelerated and
enhanced immune response upon re-infection with the same pathogen,. Since the outbreak …

Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy: Study examines how definitions and thresholds of vaccine efficacy, coupled with different …

AD Paltiel, JL Schwartz, A Zheng, RP Walensky - Health Affairs, 2021 - healthaffairs.org
The global effort to develop a coronavirus disease 2019 (COVID-19) vaccine is on track to
produce one or more authorized vaccines. We examine how different definitions and …

Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study

PC Jentsch, M Anand, CT Bauch - The Lancet Infectious Diseases, 2021 - thelancet.com
Background During the COVID-19 pandemic, authorities must decide which groups to
prioritise for vaccination in a shifting social–epidemiological landscape in which the success …